Determining the Structure and Function of Type IV-A Anti-CRISPRs

Bacteria face a constant existential threat in the form of infection by viruses along with other forms of mobile genetic elements, such as bacteriophage and transposable elements. To survive, bacteria and other prokaryotes have evolved various immune systems to evade these would-be invaders. One such immune system is the CRISPR-Cas system, an adaptive immune system able to record the genetic signature of invading viruses in order to recognize and destroy them should they be encountered again in the future. In this thesis I present data that sheds light on the mechanism of one particular subtype of CRISPR-Cas systems: the type IV-A1 system from Pseudomonas aeruginosa. I also report on some of the newly identified tools used by viruses and plasmids to evade this system, called anti-CRISPRs. The type IV-A1 system is unique in that unlike most CRISPR-Cas systems, it doesn’t appear to destroy or degrade the genome of invading viruses. Instead, it relies on an additional helicase protein called CasDinG to repress the expression of any genes near its target. I report data which explains the genetic signatures necessary to activate type IV-A CRISPR system, and I also explore the significance of a particular domain of the CasDinG helicase. This thesis also identifies the first-ever reported anti-CRISPRs against the type IV-A system, along with hypothesized mechanisms by which they repress immunity.